Therapeutic inhibition of spleen tyrosine kinase in inflammatory macrophages using PLGA nanoparticles for the treatment of non-alcoholic steatohepatitis-Reference-Cited by-同舟云学术

Therapeutic inhibition of spleen tyrosine kinase in inflammatory macrophages using PLGA nanoparticles for the treatment of non-alcoholic steatohepatitis

Published:2018-10 Issue: Volume:288 Page:227-238
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Kurniawan Dhadhang Wahyu,Jajoriya Arun Kumar,Dhawan Garima,Mishra Divya,Argemi Josepmaria^ORCID,Bataller Ramon,Storm Gert,Mishra Durga Prasad,Prakash Jai,Bansal Ruchi^ORCID

Funder

Health Research

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference40 articles.

1. Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies;Pimpin;J. Hepatol.,2018

2. Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications;Francque;J. Hepatol.,2016

3. Non-alcoholic fatty liver disease and dyslipidemia: an update;Katsiki;Metabolism,2016

4. Nonalcoholic fatty future disease;Polyzos;Metabolism,2016

5. Nonalcoholic Steatohepatitis (NASH) and Hepatic Fibrosis: Emerging Therapies;Wattacheril;Annu. Rev. Pharmacol. Toxicol.,2018

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-invasive diagnosis of liver fibrosis via MRI using targeted gadolinium-based nanoparticles;European Journal of Nuclear Medicine and Molecular Imaging;2024-09-05

2. Recent updates in applications of nanomedicine for the treatment of hepatic fibrosis;Beilstein Journal of Nanotechnology;2024-08-23

3. Nanoformulations for the diagnosis and treatment of metabolic dysfunction-associated steatohepatitis;Acta Biomaterialia;2024-08

4. PREPARATION, CHARACTERIZATION, AND TOXICITY STUDY OF ANDROGRAPHIS PANICULATA ETHANOL EXTRACT POLY-LACTIC-CO-GLYCOLIC ACID (PLGA) NANOPARTICLES IN RAW 264.7 CELLS;International Journal of Applied Pharmaceutics;2024-07-07

5. Macrophage Perspectives in Liver Diseases: Programmed Death, Related Biomarkers, and Targeted Therapy;Biomolecules;2024-06-14